RxDoctor Payments Data

Heather Alder

Nurse Practitioner · Greenfield, INNPI 1578936530

Payments from drug & device makers

$649in general payments, 2019–2025

Across 38 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$149
  • Lilly USA, LLC$95
  • Exact Sciences$76
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$58
  • Corium, LLC$54
  • AstraZeneca$45
  • plus $171 from 7 others

What the payments were for

  • Food & beverage$649100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$649 in reported general payments places this provider in the 65th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$410
Medicare patients
27
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol49$45,406
OzempicSemaglutide35$35,169
JardianceEmpagliflozin35$30,904
JanuviaSitagliptin Phosphate21$25,250
EliquisApixaban32$21,116
RybelsusSemaglutide15$19,559
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$12,815
Breo ElliptaFluticasone/Vilanterol24$12,811
TrulicityDulaglutide13$12,719
Spiriva HandihalerTiotropium Bromide18$10,541
Spiriva RespimatTiotropium Bromide12$9,447
SymbicortBudesonide/Formoterol Fumarate23$7,603
Albuterol Sulfate HfaAlbuterol Sulfate170$4,236
Duloxetine Hcl66$4,026
Fluticasone-SalmeterolFluticasone Propion/Salmeterol30$2,815

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$45$53,00972 claims
GSKTrelegy Ellipta, Breo Ellipta$17$25,62640 claims
Lilly USA, LLCTrulicity$95$12,71913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Greenfield

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →